title: The ARGA study with Italian general practitioners: prescriptions for allergic rhinitis and adherence to ARIA guidelines.
abstract: BACKGROUND
  General practitioners (GPs) are the healthcare professionals to whom patients with rhinitis firstly refer for their symptoms.
  
  
  OBJECTIVE
  In the present study, we assessed drug prescriptions for allergic rhinitis (AR) and evaluated prescriptive adherence to ARIA treatment guidelines.
  
  
  METHODS
  Data on 1379 AR patients were collected by 107 Italian GPs. Adherence to ARIA guidelines was evaluated according to AR severity classification.
  
  
  RESULTS
  AR was diagnosed by GPs as mild intermittent for 46.2% of patients, mild persistent for 26.6%, moderate-severe intermittent for 20.2%, and moderate-severe persistent for 7%; 43.7% of AR patients had concomitant asthma. The most frequently prescribed therapeutic groups were antihistamines (anti-H, 76%) and nasal corticosteroids (NCS, 46%). Anti-H were significantly used more often to treat AR alone than AR + asthma (85 vs. 68%, p < 0.001), whereas NCS were used more often to treat AR + asthma than AR alone (50 vs. 42%, p = 0.01). Among patients with only mild intermittent AR, 39% were prescribed combined therapy. Among patients with moderate-severe persistent AR, 30% of those with AR alone and 18% of those with AR + asthma were prescribed monotherapy based on anti-H. GPs were more compliant with ARIA guidelines while treating AR alone (57%) than AR + asthma (46%) patients. The adherence increased according to the severity grade and was satisfactory for moderate-severe persistent AR (89% for AR alone and 95% for AR + asthma).
  
  
  CONCLUSIONS
  Adherence to ARIA guidelines is satisfactory only for treatment of more severe patients, thus GPs often tend to treat patients independently from ARIA guidelines. Since prescription data only provide limited information to judge prescribing quality, some deviation from the gold standard are to be expected.
authors.affiliation: Pulmonary Environmental Epidemiology Unit, CNR Institute of Clinical Physiology, Pisa, Italy. saramaio@ifc.cnr.it
authors.forename: S
authors.initials: S
authors.lastname: Maio
authors.forename: M
authors.initials: M
authors.lastname: Simoni
authors.forename: S
authors.initials: S
authors.lastname: Baldacci
authors.forename: A
authors.initials: A
authors.lastname: Angino
authors.forename: F
authors.initials: F
authors.lastname: Martini
authors.forename: S
authors.initials: S
authors.lastname: Cerrai
authors.forename: G
authors.initials: G
authors.lastname: Sarno
authors.forename: P
authors.initials: P
authors.lastname: Silvi
authors.forename: M
authors.initials: M
authors.lastname: Borbotti
authors.forename: A P
authors.initials: AP
authors.lastname: Pala
authors.forename: M
authors.initials: M
authors.lastname: Bresciani
authors.forename: P L
authors.initials: PL
authors.lastname: Paggiaro
authors.forename: G
authors.initials: G
authors.lastname: Viegi
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D001249:Asthma / Q000188:drug therapy / Q000473:pathology; D005260:Female; D058005:General Practitioners; D019983:Guideline Adherence; D006633:Histamine Antagonists / Q000008:administration & dosage*; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D065631:Rhinitis, Allergic; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index
chemical_list: D000305:Adrenal Cortex Hormones; D006633:Histamine Antagonists